The Taisho Pharmaceutical Group undertakes environmental activities based on its Fundamental Policy and Code of Conduct and its Fourth Fundamental Environmental Plan (April 1, 2016-March 31, 2021) established in July 2016. We report the policies that are the premise to these activities as well as management systems, objectives and achievements.
The Taisho Pharmaceutical Group reports on activities aimed at minimizing environmental load such as reduction of CO2 emissions and final landfill disposal amount as well as the effective utilization of water resources and prevention of air pollution and water contamination, which are designated priority environmental issues.
Methods and Data
We explain the scope of environmental reporting as well as calculations of CO2 and NOx emissions on this website.
We provide PDFs of our Environmental Report summarizing our environmental activities for the fiscal year as well as a Data section comprising detailed data.